Eli Lilly and Company (BVMF:LILY34)
Brazil · Delayed Price · Currency is BRL 183.60
+3.61 (2.01%)
At close: Feb 6, 2026
Eli Lilly and Company Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | - | 10,590 | 5,240 | 6,245 | 5,582 |
Depreciation & Amortization | - | 1,767 | 1,527 | 1,523 | 1,548 |
Loss (Gain) From Sale of Assets | - | -223.8 | -1,879 | -156.5 | -216 |
Asset Writedown & Restructuring Costs | - | 3,280 | 3,800 | 908.5 | 970.1 |
Loss (Gain) From Sale of Investments | - | 49.8 | 23.5 | 420 | -178 |
Stock-Based Compensation | - | 645.6 | 628.5 | 371.1 | 342.8 |
Other Operating Activities | - | -1,906 | -2,046 | -1,724 | 330.3 |
Change in Accounts Receivable | - | -2,155 | -2,451 | -299.6 | -1,278 |
Change in Inventory | - | -2,507 | -1,425 | -599.7 | -235.9 |
Change in Accounts Payable | - | 2,609 | 4,274 | 1,692 | -1,014 |
Change in Other Net Operating Assets | - | -3,331 | -3,453 | -793.5 | 1,515 |
Operating Cash Flow | - | 8,818 | 4,240 | 7,586 | 7,366 |
Operating Cash Flow Growth | - | 107.96% | -44.10% | 2.98% | 13.33% |
Capital Expenditures | - | -5,058 | -3,448 | -1,854 | -1,310 |
Cash Acquisitions | - | -947.7 | -1,044 | -327.2 | -747.4 |
Sale (Purchase) of Intangibles | - | -2,745 | -2,340 | -1,035 | -452.6 |
Investment in Securities | - | -253.3 | -128.7 | -244 | -166 |
Other Investing Activities | - | -298.2 | -191.9 | -302.2 | -191.7 |
Investing Cash Flow | - | -9,302 | -7,153 | -3,763 | -2,868 |
Short-Term Debt Issued | - | - | 4,691 | 1,498 | - |
Long-Term Debt Issued | - | 11,417 | 3,959 | - | 2,411 |
Total Debt Issued | - | 11,417 | 8,650 | 1,498 | 2,411 |
Short-Term Debt Repaid | - | -1,852 | - | - | -4 |
Long-Term Debt Repaid | - | -664.2 | - | -1,560 | -1,905 |
Total Debt Repaid | - | -2,516 | - | -1,560 | -1,909 |
Net Debt Issued (Repaid) | - | 8,901 | 8,650 | -62 | 501.4 |
Repurchase of Common Stock | - | -2,500 | -750 | -1,500 | -1,250 |
Common Dividends Paid | - | -4,680 | -4,069 | -3,536 | -3,087 |
Other Financing Activities | - | -490.6 | -335 | -308.9 | -295.9 |
Financing Cash Flow | - | 1,230 | 3,496 | -5,407 | -4,131 |
Foreign Exchange Rate Adjustments | - | -296.7 | 168.6 | -167.6 | -205.7 |
Net Cash Flow | - | 449.8 | 751.6 | -1,752 | 161.4 |
Free Cash Flow | - | 3,760 | 792.5 | 5,731 | 6,056 |
Free Cash Flow Growth | - | 374.46% | -86.17% | -5.36% | 18.48% |
Free Cash Flow Margin | - | 8.35% | 2.32% | 20.08% | 21.39% |
Free Cash Flow Per Share | - | 4.16 | 0.88 | 6.34 | 6.64 |
Cash Interest Paid | - | 577.5 | 404.2 | 323.7 | 338 |
Cash Income Tax Paid | - | 6,562 | 5,559 | 2,673 | 1,599 |
Levered Free Cash Flow | - | 1,320 | 277.58 | 5,276 | 5,461 |
Unlevered Free Cash Flow | - | 1,808 | 581.26 | 5,483 | 5,673 |
Change in Working Capital | - | -5,385 | -3,055 | -0.8 | -1,013 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.